Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Entheon Biomedical Corp
(OP:
ENTBF
)
0.1006
-0.0087 (-7.96%)
Streaming Delayed Price
Updated: 2:15 PM EDT, Aug 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
540
Open
0.1006
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.1093
Today's Range
0.0660 - 0.1006
52wk Range
0.0043 - 0.2000
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
World Class Leaders In Psychedelics Form Benzinga's Psychedelic Advisory Council—Get To Know Them
August 30, 2022
The Benzinga Psychedelics Advisory Council was introduced in March of 2022 with the sustained goal of better informing investors and general audience about the psychedelics financial and business...
Via
Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Poised to Accelerate Its CYB004 Clinical Development Program
August 03, 2022
Via
Investor Brand Network
Performance
YTD
+1259.46%
+1259.46%
1 Month
+138.95%
+138.95%
3 Month
-31.38%
-31.38%
6 Month
+1337.14%
+1337.14%
1 Year
+520.99%
+520.99%
More News
Read More
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Acquires DMT Study Expected to Accelerate Clinical Development Path of CYB004
July 11, 2022
Via
Investor Brand Network
Psyched: Elon Musk Tweets About Psychedelics, Numinus Acquires Novamind, Colorado Gov. Signs MDMA Legalization Bill
June 15, 2022
Via
Benzinga
Largest Phase-1 DMT Study In The Netherlands, A Collaboration Between Entheon & Cybin
June 07, 2022
Via
Benzinga
Ehave Partners With Halugen Life Sciences To Create A Ketamine Precision Medicine Platform For Clinical Research
June 01, 2022
Via
Benzinga
Entheon Biomedical Announces Non-Brokered Private Placement Financing
April 05, 2022
Via
Benzinga
Benzinga's Unprecedented Psychedelics Investing Conference Lands In Miami On April 19th
February 09, 2022
Via
Benzinga
Psyched: Psychedelics ETF Launches On NYSE, Psilocybin Trial Approved For Depression, DMT Study Begins
February 07, 2022
Via
Benzinga
Psychedelics Biotech Startup Launches Phase 1 Study On Ayahuasca's Active Ingredient
February 03, 2022
Via
Benzinga
Entheon Biomedical Reports Launching Multiple Studies to Advance Psychedelic-Based Mental Health Treatments
December 13, 2021
Via
Benzinga
Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) Featured in Virtual Coverage of Benzinga’s Small Cap Conference
December 07, 2021
Via
Investor Brand Network
Compass Pathways 2.0: A New Rally In Psychedelic Stocks?
November 04, 2021
Via
Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
Entheon Biomedical Provides Corporate Update on Studies and Clinical Trials
October 27, 2021
Via
Newsfile
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
October 18, 2021
Via
Benzinga
Entheon Biomedical Acquires Lobo Genetics, Inc. in Bid to Strengthen Screening and Treatment Evaluation Tech for Psychedelics
October 06, 2021
Via
Benzinga
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
October 13, 2021
Via
Benzinga
Clinical Director of Imperial College's Center for Psychedelic Research Joins Entheon Advisory Board
August 25, 2021
Via
Newsfile
Entheon Biomedical Corp. Announces DTC Eligibility
August 24, 2021
Via
Newsfile
CORRECTION FROM SOURCE: BTV Examines the Rapidly Expanding Psychedelics Market
August 17, 2021
Via
Newsfile
BTV Examines the Rapidly Expanding Psychedelics Market
August 17, 2021
Via
Newsfile
Entheon Biomedical Announces Sponsorship of a Clinical Study to Assess the Electroneurophysiologic Effects of Ketamine
August 12, 2021
Via
Newsfile
Exposures
Product Safety
Psyched: Field Trip Uplists To Nasdaq, MindMed To Study DMT, Atai Launches New Subsidiary, AOC's Psychedelics Amendment Rejected
August 02, 2021
Via
Benzinga
Entheon Biomedical Corp. Strengthens Its Psychedelic-Assisted Protocols Through Acquisition Of Lobo Genetics
July 30, 2021
Via
Benzinga
Entheon Biomedical Corp. Acquires Lobo Genetics Inc.
July 30, 2021
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.